Vinylbital
{{short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470630727
| IUPAC_name = 5-(1-methylbutyl)-5-vinylpyrimidine-2,4,6(1H,3H,5H)-trione
| image = Vinylbital structure.svg
| image_class = skin-invert-image
| width = 150
| tradename =
| pregnancy_category =
| legal_BR = B1
| legal_BR_comment = {{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=Diário Oficial da União |language=pt-BR |publication-date=2023-04-04}}
| legal_CA = Schedule IV
| legal_US = Schedule IV
| legal_DE = Anlage II
| routes_of_administration = Oral
| bioavailability =
| metabolism = Hepatic
| elimination_half-life =
| excretion = Renal
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 2430-49-1
| ATC_prefix = N05
| ATC_suffix = CA08
| PubChem = 72135
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65109
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3W58ITX06Q
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07321
| C=11 | H=16 | N=2 | O=3
| smiles = O=C1NC(=O)NC(=O)C1(\C=C)C(C)CCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h5,7H,2,4,6H2,1,3H3,(H2,12,13,14,15,16)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KGKJZEKQJQQOTD-UHFFFAOYSA-N
}}
Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative.{{cite journal | vauthors = Breimer DD, de Boer AG | title = Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration | journal = Arzneimittel-Forschung | volume = 26 | issue = 3 | pages = 448–54 | year = 1976 | pmid = 989344 }} It was developed by Aktiebolaget Pharmacia in the 1950s.{{cite patent | inventor = Brandstrom AE | title = Manufacture of Barbituric Acid Compounds | country = US | number = 2868790 | gdate = 13 January 1959 | assign1 = Pharmacia }}{{Failed verification|reason=Patent about allyl barbiturates, not vinyl|date=March 2023}}
References
{{Reflist}}
{{Hypnotics and sedatives}}
{{GABAAR PAMs}}
{{sedative-stub}}